Skip to main content
  • person
  • Search
  • close
CMEducation Resources ScrollCall
  • person
  • Home
  • Topicschevron_right
    • chevron_leftTopics
    • Arthritis
    • Cancer
    • Cardiology
    • Diabetes
    • Diagnostic Medicine
    • Neurology
    • Prenatal Screening
    • Primary Care
    • Thrombosis
  • Submit A Question
  • About I Q&A
close

Emma Wilmot MB ChB BSc (hons) PhD FRCP - Program Chair

Emma Wilmot MB ChB BSc (hons) PhD FRCP - Program Chair

Associate Professor, University of Nottingham
Honorary Consultant Diabetologist, University Hospitals of Derby and Burton NHS FT
Founder, Diabetes Technology Network UK


Related Videos

Real World Patient Management Case Studies<br><sub>Using Individualized AGP Reports and New Glycemic Metric “Destinations" to Move Beyond HbA1c</sub> Video

Real World Patient Management Case Studies
Using Individualized AGP Reports and New Glycemic Metric “Destinations" to Move Beyond HbA1c

The Foundational Importance of Sensor-Based CGM in the Diabetes Specialist Setting<br><sub>Identifying New Glycemic Metric “Destinations” Beyond HbA1c</sub> Video

The Foundational Importance of Sensor-Based CGM in the Diabetes Specialist Setting
Identifying New Glycemic Metric “Destinations” Beyond HbA1c

Rationale for Flash Glucose Monitoring Across the Full Spectrum of Diabetes Care<br><sub>Focus on Optimizing Clinical End Points in Type 2 Diabetes</sub> Video

Rationale for Flash Glucose Monitoring Across the Full Spectrum of Diabetes Care
Focus on Optimizing Clinical End Points in Type 2 Diabetes

Real World, Interactive Case Management Sessions Utilizing Audience Response System Video

Real World, Interactive Case Management Sessions Utilizing Audience Response System

Case Studies Focused on Identifying Persons with T1 and T2 Diabetes Who Can Benefit from Patient-Directed, Sensor-Based Glucose Monitoring

Sensor-Based Glucose Monitoring/Real World Studies and Applications For The Type 1 and Type 2 Diabetes Population Video

Sensor-Based Glucose Monitoring/Real World Studies and Applications For The Type 1 and Type 2 Diabetes Population

Disclaimer:
Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Clinical Webcasts®

Powered by BroadcastMedBROADCASTMED